STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc announced the purchase and cancellation of 930,345 ordinary shares under the second tranche of its buyback programme. Reported trade prices ranged between £360.90 and £367.00 with a reported volume-weighted average price of £363.4411. After settlement the company states its registered share capital is 8,970,871,750 ordinary shares, of which 3,880,205 are held as treasury, leaving 8,966,991,545 ordinary shares with voting rights. The announcement points shareholders to a full trade breakdown and notes the release does not constitute an offer for securities.

Haleon plc ha comunicato l'acquisto e la cancellazione di 930.345 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto. I prezzi riportati delle operazioni sono stati compresi tra £360,90 e £367,00, con un prezzo medio ponderato per volume di £363,4411. Dopo il regolamento, la società dichiara che il capitale sociale registrato è composto da 8.970.871.750 azioni ordinarie, di cui 3.880.205 sono detenute come azioni proprie, lasciando 8.966.991.545 azioni ordinarie con diritto di voto. L'avviso rimanda gli azionisti al dettaglio completo delle operazioni e precisa che la comunicazione non costituisce un'offerta di titoli.

Haleon plc anunció la compra y cancelación de 930.345 acciones ordinarias en el marco de la segunda fase de su programa de recompra. Los precios reportados de las transacciones oscilaron entre £360,90 y £367,00, con un precio medio ponderado por volumen de £363,4411. Tras la liquidación, la compañía indica que su capital social registrado es de 8.970.871.750 acciones ordinarias, de las cuales 3.880.205 se mantienen en tesorería, quedando 8.966.991.545 acciones ordinarias con derecho a voto. El comunicado remite a los accionistas al desglose completo de las operaciones y aclara que esta nota no constituye una oferta de valores.

Haleon plc는 자사 주식 환매 프로그램의 두 번째 트랜치에서 930,345주 보통주를 매입 및 소각했다고 발표했습니다. 보고된 거래 가격은 £360.90에서 £367.00 사이였으며, 거래량 가중 평균 가격은 £363.4411였습니다. 결제 후 회사는 등록 자본금이 8,970,871,750주 보통주이며, 이 중 3,880,205주는 자사주로 보유8,966,991,545주가 의결권 있는 보통주로 남아 있다고 밝혔습니다. 공고는 주주들에게 전체 거래 내역을 참조하라고 안내하며 이 발표가 증권에 대한 청약을 구성하지 않는다고 명시하고 있습니다.

Haleon plc a annoncé l'achat et l'annulation de 930 345 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat. Les prix déclarés des transactions variaient entre £360,90 et £367,00, avec un prix moyen pondéré par les volumes de £363,4411. Après règlement, la société indique que son capital social enregistré s'élève à 8 970 871 750 actions ordinaires, dont 3 880 205 sont détenues en trésorerie, laissant 8 966 991 545 actions ordinaires avec droit de vote. L'annonce renvoie les actionnaires au détail complet des transactions et précise que cette communication ne constitue pas une offre de titres.

Haleon plc gab den Erwerb und die Vernichtung von 930.345 Stammaktien im Rahmen der zweiten Tranche seines Rückkaufprogramms bekannt. Die gemeldeten Handelspreise lagen zwischen £360,90 und £367,00, mit einem volumen­gewichteten Durchschnittspreis von £363,4411. Nach Abwicklung gibt das Unternehmen an, dass das eingetragene Grundkapital 8.970.871.750 Stammaktien beträgt, von denen 3.880.205 als eigene Aktien gehalten werden, wodurch 8.966.991.545 stimmberechtigte Stammaktien verbleiben. Die Mitteilung verweist die Aktionäre auf die vollständige Handelsaufstellung und stellt klar, dass die Veröffentlichung kein Angebot von Wertpapieren darstellt.

Positive
  • Buyback executed and cancelled, demonstrating follow-through on the announced share repurchase programme
  • Full post-settlement share capital and voting-rights figures provided, aiding regulatory transparency and shareholder calculations
  • Trade price details and link to individual trade breakdown provided in line with Market Abuse Regulation disclosure requirements
Negative
  • Transaction size is immaterial relative to total issued shares, so it is unlikely to move per-share metrics or ownership materially
  • No information on aggregate programme size or remaining authorization is provided in this notice

Insights

TL;DR: A routine share cancellation that slightly reduces share count and updates the voting-rights figure for regulatory disclosure.

The company executed and cancelled 930,345 shares under its announced buyback tranche and published post-settlement share capital and voting-rights figures. Providing the precise share counts and a link to the individual trade breakdown meets disclosure requirements under the Market Abuse Regulation and UK transparency rules. The action maintains compliance and ensures shareholders can calculate notification thresholds. The size of the cancellation relative to total issued shares is extremely small, so governance control dynamics are not materially affected.

TL;DR: Technical share repurchase with immaterial impact on outstanding shares and likely no meaningful change to per-share metrics.

The transaction details include execution prices (high £367.00, low £360.90, VWAP £363.4411) which allow transparency on execution cost. The cancelled volume of 930,345 shares against roughly 8.97 billion registered shares represents a vanishingly small percentage, so EPS and ownership percentages will be essentially unchanged. The filing appropriately updates treasury holdings and voting-rights counts for investor reference.

Haleon plc ha comunicato l'acquisto e la cancellazione di 930.345 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto. I prezzi riportati delle operazioni sono stati compresi tra £360,90 e £367,00, con un prezzo medio ponderato per volume di £363,4411. Dopo il regolamento, la società dichiara che il capitale sociale registrato è composto da 8.970.871.750 azioni ordinarie, di cui 3.880.205 sono detenute come azioni proprie, lasciando 8.966.991.545 azioni ordinarie con diritto di voto. L'avviso rimanda gli azionisti al dettaglio completo delle operazioni e precisa che la comunicazione non costituisce un'offerta di titoli.

Haleon plc anunció la compra y cancelación de 930.345 acciones ordinarias en el marco de la segunda fase de su programa de recompra. Los precios reportados de las transacciones oscilaron entre £360,90 y £367,00, con un precio medio ponderado por volumen de £363,4411. Tras la liquidación, la compañía indica que su capital social registrado es de 8.970.871.750 acciones ordinarias, de las cuales 3.880.205 se mantienen en tesorería, quedando 8.966.991.545 acciones ordinarias con derecho a voto. El comunicado remite a los accionistas al desglose completo de las operaciones y aclara que esta nota no constituye una oferta de valores.

Haleon plc는 자사 주식 환매 프로그램의 두 번째 트랜치에서 930,345주 보통주를 매입 및 소각했다고 발표했습니다. 보고된 거래 가격은 £360.90에서 £367.00 사이였으며, 거래량 가중 평균 가격은 £363.4411였습니다. 결제 후 회사는 등록 자본금이 8,970,871,750주 보통주이며, 이 중 3,880,205주는 자사주로 보유8,966,991,545주가 의결권 있는 보통주로 남아 있다고 밝혔습니다. 공고는 주주들에게 전체 거래 내역을 참조하라고 안내하며 이 발표가 증권에 대한 청약을 구성하지 않는다고 명시하고 있습니다.

Haleon plc a annoncé l'achat et l'annulation de 930 345 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat. Les prix déclarés des transactions variaient entre £360,90 et £367,00, avec un prix moyen pondéré par les volumes de £363,4411. Après règlement, la société indique que son capital social enregistré s'élève à 8 970 871 750 actions ordinaires, dont 3 880 205 sont détenues en trésorerie, laissant 8 966 991 545 actions ordinaires avec droit de vote. L'annonce renvoie les actionnaires au détail complet des transactions et précise que cette communication ne constitue pas une offre de titres.

Haleon plc gab den Erwerb und die Vernichtung von 930.345 Stammaktien im Rahmen der zweiten Tranche seines Rückkaufprogramms bekannt. Die gemeldeten Handelspreise lagen zwischen £360,90 und £367,00, mit einem volumen­gewichteten Durchschnittspreis von £363,4411. Nach Abwicklung gibt das Unternehmen an, dass das eingetragene Grundkapital 8.970.871.750 Stammaktien beträgt, von denen 3.880.205 als eigene Aktien gehalten werden, wodurch 8.966.991.545 stimmberechtigte Stammaktien verbleiben. Die Mitteilung verweist die Aktionäre auf die vollständige Handelsaufstellung und stellt klar, dass die Veröffentlichung kein Angebot von Wertpapieren darstellt.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
         99.1
21 August 2025 - “Transaction in Own Shares”
 
 
 
 
99.1
 
 
Haleon plc: Transaction in own shares
 
21 August 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 930,345 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
20 August 2025
20 August 2025
20 August 2025
Number of Shares purchased:
930,345
-
-
Highest price paid per Share (p):
367.0000
-
-
Lowest price paid per Share (p):
360.9000
-
-
Volume weighted average price paid per Share (p):
363.4411
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,970,871,750 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,966,991,545 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/1566W_1-2025-8-20.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: August 21, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

How many shares did Haleon (HLN) cancel on 21 August 2025?

Haleon cancelled 930,345 ordinary shares under the second tranche of its buyback programme.

What were the execution prices for Haleon's share purchases?

Reported trade prices ranged from £360.90 to £367.00 with a VWAP of £363.4411.

What is Haleon's updated registered share capital and number of voting shares?

Registered share capital is 8,970,871,750 ordinary shares; 3,880,205 are treasury shares, leaving 8,966,991,545 ordinary shares with voting rights.

Where can I find the full breakdown of the individual trades?

The company provided a link to the individual trade breakdown: http://www.rns-pdf.londonstockexchange.com/rns/1566W_1-2025-8-20.pdf and the announcement is on www.haleon.com/investors.

Does this announcement constitute an offer for securities?

No. The announcement explicitly states it does not constitute an offer or solicitation of an offer for securities.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

43.68B
4.49B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge